[go: up one dir, main page]

RU2002108806A - A method for the treatment of autoimmune arthritis in animals - Google Patents

A method for the treatment of autoimmune arthritis in animals

Info

Publication number
RU2002108806A
RU2002108806A RU2002108806/14A RU2002108806A RU2002108806A RU 2002108806 A RU2002108806 A RU 2002108806A RU 2002108806/14 A RU2002108806/14 A RU 2002108806/14A RU 2002108806 A RU2002108806 A RU 2002108806A RU 2002108806 A RU2002108806 A RU 2002108806A
Authority
RU
Russia
Prior art keywords
animals
treatment
autoimmune arthritis
nicotinic acid
poviargol
Prior art date
Application number
RU2002108806/14A
Other languages
Russian (ru)
Other versions
RU2232560C2 (en
Inventor
Владимир Александрович Митрофанов
Анатолий Михайлович Гнетнёв
Мария Вадимовна Федотова
Наталья Михайловна Овчинникова
Original Assignee
Саратовский научно-исследовательский институт травматологии и ортопедии
Filing date
Publication date
Application filed by Саратовский научно-исследовательский институт травматологии и ортопедии filed Critical Саратовский научно-исследовательский институт травматологии и ортопедии
Priority to RU2002108806/14A priority Critical patent/RU2232560C2/en
Priority claimed from RU2002108806/14A external-priority patent/RU2232560C2/en
Publication of RU2002108806A publication Critical patent/RU2002108806A/en
Application granted granted Critical
Publication of RU2232560C2 publication Critical patent/RU2232560C2/en

Links

Claims (3)

1. Способ лечения аутоиммунного артрита у животных, включающий применение фармакологического агента - повиаргола, отличающийся тем, что 5 мг препарата из расчета разовой дозы 0,5 мг/кг массы растворяют в 1 мл 1%-ного раствора никотиновой кислоты и полученную смесь двух препаратов вводят внутрисуставно.1. A method for the treatment of autoimmune arthritis in animals, including the use of a pharmacological agent - poviargol, characterized in that 5 mg of the drug at the rate of a single dose of 0.5 mg / kg of mass is dissolved in 1 ml of a 1% solution of nicotinic acid and the resulting mixture of two drugs administered intraarticularly. 2. Способ по п.1, отличающийся тем, что препарат никотиновой кислоты применяют из расчета разовой дозы 1 мг/кг массы.2. The method according to claim 1, characterized in that the nicotinic acid preparation is used based on a single dose of 1 mg / kg of body weight. 3. Способ по пп.1 и 2, отличающийся тем, что смесь растворов препаратов повиаргола и никотиновой кислоты вводят в количестве 0,02 мл 1 раз в 4 дня в течение 16 дней.3. The method according to claims 1 and 2, characterized in that the mixture of solutions of the preparations of poviargol and nicotinic acid is administered in an amount of 0.02 ml 1 time in 4 days for 16 days.
RU2002108806/14A 2002-04-05 2002-04-05 Method for treating autoimune arthritis in animals RU2232560C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2002108806/14A RU2232560C2 (en) 2002-04-05 2002-04-05 Method for treating autoimune arthritis in animals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2002108806/14A RU2232560C2 (en) 2002-04-05 2002-04-05 Method for treating autoimune arthritis in animals

Publications (2)

Publication Number Publication Date
RU2002108806A true RU2002108806A (en) 2003-12-10
RU2232560C2 RU2232560C2 (en) 2004-07-20

Family

ID=33412390

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002108806/14A RU2232560C2 (en) 2002-04-05 2002-04-05 Method for treating autoimune arthritis in animals

Country Status (1)

Country Link
RU (1) RU2232560C2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2305328C1 (en) * 2005-11-21 2007-08-27 Ярославская государственная медицинская академия Method for modeling rheumatoid arthritis cases
RU2347572C1 (en) * 2007-05-31 2009-02-27 Федеральное государственное учреждение "Саратовский научно-исследовательский институт травматологии и ортопедии Федерального агентства по здравоохранению и социальному развитию" (ФГУ "СарНИИТО Росздрава") Method for local therapy of antigen-induced arthritis
RU2341268C1 (en) * 2007-07-04 2008-12-20 Федеральное государственное учреждение "Саратовский научно-исследовательский институт травматологии и ортопедии Федерального агентства по высокотехнологичной медицинской помощи" (ФГУ "СарНИИТО Росмедтехнологий") Method of intra-articular treatment of antigen-induced arthritis
RU2456988C1 (en) * 2011-04-21 2012-07-27 Государственное образовательное учреждение высшего профессионального образования "Мордовский государственный университет им. Н.П. Огарева" Method of treating posttraumatic knee arthritis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1272994B (en) * 1994-05-25 1997-07-01 Giampiero Valletta USE OF PRODUCTS CONTAINING MAGNESIUM IN THE THERAPY AND PROPHYLAXIS OF NEOPLASTIC DISEASES AND SELF-IMMUNITARY DISEASES.-
WO1997006790A1 (en) * 1995-08-14 1997-02-27 Oxigene, Inc. Carotenoid-nicotinamide-zinc compositions and methods of treatment using same

Similar Documents

Publication Publication Date Title
US4778810A (en) Nasal delivery of caffeine
Fabro et al. Toxicity and teratogenicity of optical isomers of thalidomide
Li et al. Transport, metabolism and elimination mechanisms of anti-HIV agents
JPH02184628A (en) Curing for arthritis disease and inflammation disease
CA2326517A1 (en) New galenic preparations of meloxicam for oral administration
JP2005515966A5 (en)
MY102459A (en) Oral sustained release pharmaceutical preparation.
KR20110021823A (en) Analgesic resistance inhibitors
JPH05506431A (en) Use of suramin for the treatment of rheumatic diseases
Yeom et al. Pharmacokinetics and bioavailability of carbovir, a carbocyclic nucleoside active against human immunodeficiency virus, in rats
RU2002108806A (en) A method for the treatment of autoimmune arthritis in animals
KR20060004959A (en) How to improve diuretic activity in individual subjects with renal impairment
WO2000026185A3 (en) Omeprazole solution and method of using same
JPH01246218A (en) Immunoregulator
JPH06172187A (en) Remedy for muscular dystrophy
CZ79593A3 (en) Antitussive preparation
RU99112967A (en) METHOD FOR TREATMENT AND PREVENTION OF PIG DYSENTERY
RU2002104753A (en) Method for the prevention and treatment of cattle leukemia
US3764679A (en) Iodinin as an anti-hypertensive agent
RU97116119A (en) DRUG FOR THE TREATMENT OF ANIMAL PYROPLASMIDOSIS AND METHOD OF ITS APPLICATION
SU1764654A1 (en) Remedy for alcoholic treatment
RU2057537C1 (en) Medicinal agent of immunomodulating action based on thymosine
US3806594A (en) Method of reducing involuntary movements associated with cerebral palsy using clorazepate dipotassium
RU94044812A (en) Method of patient ataralgesia at stomatologic operations
RU1801002C (en) Method for treating respiratory diseases in calves